Stereotaxis Inc

NYSE MKT:STXS USA Medical Instruments & Supplies
Market Cap
$176.38 Million
Market Cap Rank
#17289 Global
#6571 in USA
Share Price
$1.89
Change (1 day)
-1.05%
52-Week Range
$1.60 - $3.57
All Time High
$10.17
About

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more

Stereotaxis Inc (STXS) - Total Assets

Latest total assets as of September 2025: $45.59 Million USD

Based on the latest financial reports, Stereotaxis Inc (STXS) holds total assets worth $45.59 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Stereotaxis Inc - Total Assets Trend (2000–2024)

This chart illustrates how Stereotaxis Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Stereotaxis Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Stereotaxis Inc's total assets of $45.59 Million consist of 56.6% current assets and 43.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 26.2%
Accounts Receivable $3.82 Million 8.2%
Inventory $8.33 Million 17.8%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $7.36 Million 15.8%
Goodwill $3.76 Million 8.1%

Asset Composition Trend (2000–2024)

This chart illustrates how Stereotaxis Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Stereotaxis Inc's current assets represent 56.6% of total assets in 2024, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 26.2% of total assets in 2024, up from 0.0% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2000.
  • Asset Diversification: The largest asset category is inventory at 17.8% of total assets.

Stereotaxis Inc Competitors by Total Assets

Key competitors of Stereotaxis Inc based on total assets are shown below.

Company Country Total Assets
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
China CN¥3.82 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.46 Billion
Andon Health Co Ltd
SHE:002432
China CN¥28.98 Billion
Allmed Medical Products Co Ltd Class A
SHE:002950
China CN¥5.35 Billion
Inix Technologies Holdings Bhd
KLSE:0094
Malaysia RM72.53 Million
Focus Point Holdings Bhd
KLSE:0157
Malaysia RM328.19 Million
Careplus Group Bhd
KLSE:0163
Malaysia RM286.61 Million
LKL International Bhd
KLSE:0182
Malaysia RM173.46 Million

Stereotaxis Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.48 - 2.92

Moderate asset utilization - Stereotaxis Inc generates 0.58x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -55.19% - 0.63%

Negative ROA - Stereotaxis Inc is currently not profitable relative to its asset base.

Stereotaxis Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.31 1.39 3.88
Quick Ratio 0.81 0.96 3.64
Cash Ratio 0.00 0.00 0.00
Working Capital $6.29 Million $ 8.09 Million $ 39.14 Million

Stereotaxis Inc - Advanced Valuation Insights

This section examines the relationship between Stereotaxis Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 30.09
Latest Market Cap to Assets Ratio 2.67
Asset Growth Rate (YoY) 11.5%
Total Assets $46.72 Million
Market Capitalization $124.84 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Stereotaxis Inc's assets at a significant premium ( 2.67x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Stereotaxis Inc's assets grew by 11.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Stereotaxis Inc (2000–2024)

The table below shows the annual total assets of Stereotaxis Inc from 2000 to 2024.

Year Total Assets Change
2024-12-31 $46.72 Million +11.49%
2023-12-31 $41.91 Million -21.54%
2022-12-31 $53.41 Million -12.42%
2021-12-31 $60.98 Million +9.97%
2020-12-31 $55.46 Million +27.24%
2019-12-31 $43.58 Million +135.41%
2018-12-31 $18.51 Million +73.57%
2017-12-31 $10.67 Million -49.12%
2016-12-31 $20.97 Million +9.04%
2015-12-31 $19.23 Million -19.49%
2014-12-31 $23.88 Million -23.15%
2013-12-31 $31.08 Million -3.39%
2012-12-31 $32.17 Million -19.45%
2011-12-31 $39.93 Million -39.28%
2010-12-31 $65.76 Million +17.18%
2009-12-31 $56.12 Million -5.59%
2008-12-31 $59.44 Million -1.71%
2007-12-31 $60.48 Million -12.72%
2006-12-31 $69.29 Million +89.02%
2005-12-31 $36.66 Million -48.50%
2004-12-31 $71.19 Million +90.73%
2003-12-31 $37.32 Million +13.37%
2002-12-31 $32.92 Million +30.79%
2000-12-31 $25.17 Million --